Back to Trexquant Investment LP Trexquant Investment LP

REGNREGN
19 quarters

Position history for Trexquant Investment LPTrexquant Investment LP's holdings in REGENERON PHARMACEUTICALS

Yes. Trexquant Investment holds 41,839 shares of REGN (Regeneron Pharmaceuticals), worth $26.1M, as of its Q2 2026 13F filing. It increased the position from 11,072 shares in Q1 2026. Trexquant Investment has held REGN since Q4 2025, across 3 quarterly 13F filings. REGN is 0.2% of Trexquant Investment's reported 13F portfolio.

Current Value

$26.1M

Current Shares

41,839

Total Value Change

+$23.7M

Total Shares Change

+34,213

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
41,839
+277.9%
$26.1M0.2%$622.81
55
2026-Q1
Increased
11,072
+225.4%
$8.6M0.1%$770.59
44
2025-Q4
New
3,403
-
$2.6M0.0%$768.90
36
2025-Q3
Exited
0
-100.0%
$00.0%$559.40
0
2025-Q2
Decreased
11,936
-79.0%
$6.3M0.1%$521.53
0
2025-Q1
Increased
56,931
+0.5%
$36.1M0.4%$629.11
35
2024-Q4
Increased
56,625
+305.9%
$40.3M0.5%$705.67
56
2024-Q3
New
13,951
-
$14.7M0.2%$1,041.41
46
2024-Q1
Exited
0
-100.0%
$00.0%$953.49
0
2023-Q4
New
5,891
-
$5.2M0.1%$870.08
45
2022-Q1
Exited
0
-100.0%
$00.0%$691.89
0
2021-Q4
Decreased
2,230
-79.5%
$1.4M0.1%$625.62
0
2021-Q3
New
10,855
-
$6.6M0.5%$599.52
53
2021-Q1
Exited
0
-100.0%
$00.0%$468.72
0
2020-Q4
New
3,717
-
$1.8M0.2%$478.59
43
2020-Q1
Exited
0
-100.0%
$00.0%$483.73
0
2019-Q4
Decreased
1,980
-77.3%
$743,0000.0%$371.97
0
2019-Q3
Increased
8,702
+14.1%
$2.4M0.2%$274.81
36
2019-Q2
New
7,626
-
$2.4M0.2%$310.07
43

Other major holders of REGN: FMR LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used